Usted buscó: acetyl (Italiano - Griego)

- acetyl isovaleryl tylosin
- acetyl isovaleryl tylosin tartrate

acetyl isovaleryl tylosin tartrate
acetyl isovaleryl tylosin tartrate

l-lysine-n-acetyl-l- cysteinate
l- lysine- n- acetyl- l - cysteinate

acetyl isovaleryl porcine - 18.10.1995 tylosin tartrate - 13.10.1999 - 195 days - 1260 days
acetyl isovaleryl porcine - 18. 10. 1995 tylosin tartrate - 13. 10. 1999 - 195 days - 1260 days

titolo del documento note for guidance on clinical investigation of medicinal products for the treatment of diabetes mellitus note for guidance on clinical investigation of anti-depressive agents note for guidance on clinical investigation of medicinal products for pain treatment position paper on new modified formulations of acetyl salicylic acid in the secondary prevention of cardiovascular events note for guidance on clinical investigation of medicinal products for treatment of peripheral arterial occlusive disease concept paper on the revision of the note for guidance on evaluation of new anti-bacterial medicinal product (cpmp/ ewp/ 558/ 95) and the note for guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial products points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
Τίτλος εγγράφου note for guidance on clinical investigation of medicinal products for the treatment of diabetes mellitus note for guidance on clinical investigation of anti- depressive agents note for guidance on clinical investigation of medicinal products for pain treatment position paper on new modified formulations of acetyl salicylic acid in the secondary prevention of cardiovascular events note for guidance on clinical investigation of medicinal products for treatment of peripheral arterial occlusive disease concept paper on the revision of the note for guidance on evaluation of new anti- bacterial medicinal product (cpmp/ ewp/ 558/ 95) and the note for guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial products points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications: